The 2026 China Pharmaceutical Industry Expo (CHINA MEDICINE CONNECT EXPO) will grandly open on September 4-5 in Suzhou, China, helping everyone “find your best partner in China.” This is not just an industry gathering; it is an inevitable convergence of global pharmaceutical innovation elements in the East, as well as a strategic hub for the comprehensive upgrading of China’s pharmaceutical industry.

Full-Chain Resource Coverage: 800+ pharma companies, Top 100 Biotech, Top 50 CXO, innovation divisions of 300+ traditional pharma companies, and direct access to decision-makers from 200+ active investment institutions and MNC BD.

Full-Chain Resource Coverage: 800+ pharma companies, Top 100 Biotech, Top 50 CXO, innovation divisions of 300+ traditional pharma companies, and direct access to decision-makers from 200+ active investment institutions and MNC BD.

Powerful Scenario Enablement: Over 15 million content impressions annually, 60+ top-tier thematic live streams, and the solid foundation of eight successful sessions of the CMC-China Expo, a 10,000+ participant event. The 2026 China Pharmaceutical Industry Full-Chain Ecosystem Conference is expected to attract over 20,000 attendees, defining the industry's future across five dimensions:

Source of Innovation & Capital Matchmaking: A closed-door investment and financing summit will be established, precisely connecting 300+ promising Biotech companies with top-tier domestic and international capital, in search of the "next super molecule."

Pioneering Wisdom & Thought Leadership: A New Drug Founders Annual Meeting (500 participants) will bring together policymakers, FDA/EMA review experts, and MNC BD leaders to discuss cutting-edge regulatory and BD strategies.

Panoramic Display & Trend Insight: Focus on cutting-edge areas such as CGT, XDC, TIDES, and protein degradation, with dedicated exhibition areas and forums, offering one-stop insights into the future of technology.

Ecosystem Coupling & Deal Facilitation: Leveraging the Pharma Industry Network hub, deeply operate BD and NewCo sessions to efficiently match pipelines, technologies, and capital, driving transactions forward.

Global Connectivity & Mutual Enablement: Build a two-way bridge between local and global markets, helping Chinese innovation integrate into the world while attracting global resources to deeply cultivate China.

Pharma Growth? Find the Pharma Industry Network!

Nine years of deep cultivation. The ecosystem is complete.

Now, we invite you to answer the call of the East,
On this most dynamic and vibrant ground of innovation.
Face capital directly, connect globally, and gather the ecosystem.
Together, let us open a new chapter for China's pharmaceutical industry.

Powerful Scenario Enablement: Over 15 million content impressions annually, 60+ top-tier thematic live streams, and the solid foundation of eight successful sessions of the CMC-China Expo, a 10,000+ participant event. The 2026 China Pharmaceutical Industry Full-Chain Ecosystem Conference is expected to attract over 20,000 attendees, defining the industry's future across five dimensions:

Source of Innovation & Capital Matchmaking: A closed-door investment and financing summit will be established, precisely connecting 300+ promising Biotech companies with top-tier domestic and international capital, in search of the "next super molecule."

Pioneering Wisdom & Thought Leadership: A New Drug Founders Annual Meeting (500 participants) will bring together policymakers, FDA/EMA review experts, and MNC BD leaders to discuss cutting-edge regulatory and BD strategies.

Panoramic Display & Trend Insight: Focus on cutting-edge areas such as CGT, XDC, TIDES, and protein degradation, with dedicated exhibition areas and forums, offering one-stop insights into the future of technology.

Ecosystem Coupling & Deal Facilitation: Leveraging the Pharma Industry Network hub, deeply operate BD and NewCo sessions to efficiently match pipelines, technologies, and capital, driving transactions forward.

Global Connectivity & Mutual Enablement: Build a two-way bridge between local and global markets, helping Chinese innovation integrate into the world while attracting global resources to deeply cultivate China.

Pharma Growth? Find the Pharma Industry Network!

Nine years of deep cultivation. The ecosystem is complete.

Now, we invite you to answer the call of the East,
On this most dynamic and vibrant ground of innovation.
Face capital directly, connect globally, and gather the ecosystem.
Together, let us open a new chapter for China's pharmaceutical industry.